Contribute Try STAT+ Today

WASHINGTON — The top ranking Democrat on the Senate health committee has “a number of concerns” with how the Food and Drug Administration might regulate medical software such as smartphone apps.

“It is essential that changes to FDA’s regulatory framework are done in compliance with the current statutory framework and do not compromise public safety,” the senators wrote in a letter to the FDA Wednesday.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Just imagine what they will do with that Data. Facebook and several other companies have run psychological tests on unsuspecting users. They can link this data with reactions to advertising, fake news or political ads on Facebook or other Social Media. The details and the underhanded dealings of the corporations involved have not been discussed in any mass media.

Comments are closed.